PD-L1 PET/CT imaging shows partial tumor saturation during atezolizumab treatment

被引：0

作者：

Smit, L. M. ^{[1
]}

Hooiveld, J. ^{[1
]}

van de Donk, P. P. ^{[1
]}

de Ruijter, L. Kist ^{[1
]}

Kok, I. C. ^{[1
]}

Winkel, C. A. J. ^{[1
]}

Giesen, D. ^{[2
]}

Lub-de Hooge, M. N. ^{[3
]}

Brouwers, A. H. ^{[2
]}

Oosting, S. F. ^{[4
]}

Bensch, F. ^{[5
]}

Schroder, C. P. ^{[1
]}

Jalving, M. ^{[1
]}

Elias, S. G. ^{[6
]}

Gietema, J. A. ^{[1
]}

Deurloo, R. J. ^{[7
]}

Williams, S. P. ^{[8
]}

Ungewickell, A. ^{[9
]}

De Groot, D. J. A. ^{[1
]}

de Vries, E. G. E. ^{[1
]}

机构：

[1] Univ Med Ctr Groningen, Med Oncol, Groningen, Netherlands

[2] Univ Med Ctr Groningen, Nucl Med & Mol Imaging, Groningen, Netherlands

[3] Univ Med Ctr Groningen, Clin Pharm & Pharmacol, Groningen, Netherlands

[4] Univ Med Ctr Groningen, Med Oncol, Groningen, Netherlands

[5] Univ Med Ctr Groningen, Pulm Dis, Groningen, Netherlands

[6] Univ Med Ctr Utrecht, Epidemiol & Hlth Econ, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands

[7] F Hoffmann La Roche Ltd, Translat Med Oncol, Basel, Switzerland

[8] Genentech Inc, Biomed Imaging Res Biol, San Francisco, CA USA

[9] Genentech Inc, Clin Dev Hematol Oncol, San Francisco, CA USA

来源：

EUROPEAN JOURNAL OF CANCER | 2024年 / 211卷

关键词：

D O I：

10.1016/j.ejca.2024.114777

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PB248

引用

页码：S100 / S100

页数：1

共 50 条

[31] Noninvasive Imaging of Tumor PD-L1 Expression Using Radiolabeled Anti-PD-L1 Antibodies
Heskamp, Sandra
Hobo, Willemijn
Molkenboer-Kuenen, Janneke D. M.
Olive, Daniel
Oyen, Wim J. G.
Dolstra, Harry
Boerman, Otto C.
CANCER RESEARCH, 2015, 75 (14) : 2928 - 2936
[32] High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment
Sanchez-Magraner, Lissete
Miles, James
Baker, Claire L.
Applebee, Christopher J.
Lee, Dae-Jin
Elsheikh, Somaia
Lashin, Shaimaa
Withers, Katriona
Watts, Andrew G.
Parry, Richard
Edmead, Christine
Lopez, Jose Ignacio
Mehta, Raj
Italiano, Antoine
Ward, Stephen G.
Parker, Peter J.
Larijani, Banafshe
CANCER RESEARCH, 2020, 80 (19) : 4244 - 4257
[33] Synthesis and radiolabeling of diabody fragment of anti-PD-L1-B11 antibody for PET imaging of PD-L1 in a melanoma tumor mouse model
Bansal, Aditya
Lavoie, Roxane
Lucien, Fabrice
Kethamreddy, Manasa
Dong, Haidong
Park, Sean
Pandey, Mukesh
NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S193 - S194
[34] Synthesis and evaluation of anti-PD-L1-B11 antibody fragments for PET imaging of PD-L1 in breast cancer and melanoma tumor models
Bansal, Aditya
Lavoie, Roxane R.
Lucien, Fabrice
Kethamreddy, Manasa
Wootla, Bharath
Dong, Haidong
Park, Sean S.
Pandey, Mukesh K.
SCIENTIFIC REPORTS, 2024, 14 (01):
[35] Development and evaluation of biphenyl-based small-molecule radiotracers for PET imaging of PD-L1 in tumor
Zhang, Nan
Zhu, Junyi
Hu, Xin
Zhou, Yuxuan
Wang, Qianhui
Cai, Shuyue
Xie, Quan
Qiu, Ling
Lv, Gaochao
Lin, Jianguo
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2025, 122
[36] A highly specific hydrophilic peptide for PET imaging of PD-L1 expression in tumors
Kumar, Dhiraj
Lisok, Ala
Chatterjee, Samit
Wharram, Bryan
Mease, Ronnie
Pomper, Martin
Nimmagadda, Sridhar
JOURNAL OF NUCLEAR MEDICINE, 2018, 59
[37] Evaluation of a Radiolabeled Macrocyclic Peptide as Potential PET Imaging Probe for PD-L1
Jouini, Nedra
Cardinale, Jens
Mindt, Thomas L.
CHEMMEDCHEM, 2022, 17 (12)
[38] Linear Peptide-Based PET Tracers for Imaging PD-L1 in Tumors
Zhang, Lulu
Zhang, Siqi
Wu, Jiang
Wang, Yanrong
Wu, Yuxuan
Sun, Xiaona
Wang, Xingkai
Shen, Jieting
Xie, Lin
Zhang, Yiding
Zhang, Hailong
Hu, Kuan
Wang, Feng
Wang, Rui
Zhang, Ming-Rong
MOLECULAR PHARMACEUTICS, 2023, 20 (08) : 4256 - 4267
[39] Distinct contribution of PD-L1 suppression by spatial expression of PD-L1 on tumor and non-tumor cells
Xiaoqing Zhang
Chen Cheng
Jiyan Hou
Xinyue Qi
Xin Wang
Ping Han
Xuanming Yang
Cellular & Molecular Immunology, 2019, 16 : 392 - 400
[40] Imaging PD-L1 expression with immunoPET
Wei, Junnian
Evans, Michael
JOURNAL OF NUCLEAR MEDICINE, 2018, 59

← 1 2 3 4 5 →